AGOSTINO, RITA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 318
EU - Europa 216
AS - Asia 85
Totale 619
Nazione #
US - Stati Uniti d'America 317
IE - Irlanda 89
SE - Svezia 70
CN - Cina 66
IT - Italia 26
HK - Hong Kong 13
DE - Germania 9
FR - Francia 8
BE - Belgio 6
IN - India 5
FI - Finlandia 4
ES - Italia 2
AL - Albania 1
CA - Canada 1
JP - Giappone 1
UA - Ucraina 1
Totale 619
Città #
Chandler 97
Dublin 89
Nyköping 45
Ann Arbor 22
Beijing 22
New York 22
Ashburn 20
Dearborn 15
Princeton 14
Messina 13
Jacksonville 12
Medford 11
Bremen 8
Des Moines 8
Boardman 7
Cambridge 7
Nanjing 7
Brussels 6
Seattle 6
Pune 5
Shenyang 5
Zhengzhou 5
Hangzhou 4
Sheung Shui 4
Central 3
Houston 3
Jinan 3
San Mateo 3
Changsha 2
Córdoba 2
Fiumefreddo Di Sicilia 2
Fuzhou 2
Guangzhou 2
Hebei 2
Milan 2
Nanchang 2
Riva 2
Wilmington 2
Changle 1
Clearwater 1
Haikou 1
Limeil-brévannes 1
Matawan 1
Milazzo 1
Ningbo 1
Strasbourg 1
Taizhou 1
Tappahannock 1
Tianjin 1
Totale 497
Nome #
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 80
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 73
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 63
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 58
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 57
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 55
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 55
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 55
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 53
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 48
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 43
Totale 640
Categoria #
all - tutte 2.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202067 0 3 2 2 1 15 12 5 5 19 3 0
2020/202160 6 1 25 4 9 1 1 1 0 9 2 1
2021/202297 1 9 4 4 2 0 10 3 6 15 9 34
2022/2023288 22 38 12 27 19 33 1 19 106 1 7 3
2023/202485 5 10 3 9 3 30 3 21 0 1 0 0
Totale 640